FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells

Xue,Liang; Yue,Shuyuan; Zhang,Jianning

doi:10.3892/mmr.2014.2197

FOXP1 has a low expression in human gliomas and its overexpression inhibits proliferation, invasion and migration of human glioma U251 cells

Authors:
- Liang Xue
- Shuyuan Yue
- Jianning Zhang
View Affiliations

Affiliations: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China
Published online on: April 29, 2014 https://doi.org/10.3892/mmr.2014.2197
Pages: 467-472

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to examine the clinical characteristics of forkhead box protein P1 (FoxP1) in gliomas and its role in the proliferation, invasiveness, migration and apoptosis of the human glioma U251 cell line. The expression levels of FOXP1 were first studied in operation resection specimens of glioma and normal peripheral brain tissues. The enhanced green fluorescent protein (EGFP) expression vector of FOXP1 was prepared and transfected into U251 cells. MTT, cell invasion, transwell and scratch assays were utilized to investigate the cell growth activity and the rate of apoptosis of the cells was tested by flow cytometry. Western blot analysis and quantitative polymerase chain reaction assays were employed to measure the transfection efficacy. The results revealed that FOXP1 was highly expressed in glioma, as compared with low levels detected in normal brain tissues. Following transfection with pEGFP-N1-FOXP1, the proliferation, invasiveness and migration capabilities of cells significantly decreased, whilst the rate of apoptosis was markedly enhanced (P<0.01). Furthermore, the expression of FOXP1 in U251 cells was enhanced (P<0.01). In conclusion, the present study indicated that FOXP1 is closely associated with tumorigenesis and development of glioma, as demonstrated by a reduction in the proliferation, migration and invasion of glioma cells upon FOCP1 overexpression.

View Figures

View References

1	Komotar RJ, Otten ML, Moise G and Connolly ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review. Clin Med Oncol. 2:421–422. 2008.PubMed/NCBI
2	Minniti G, De Sanctis V, Muni R, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol. 88:97–103. 2008. View Article : Google Scholar : PubMed/NCBI
3	Stupp R, Mason WP, van den Bent MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
4	Chen SM, Chen HC, Chen SJ, et al: MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. World J Surg Oncol. 11:872013. View Article : Google Scholar : PubMed/NCBI
5	Furnari FB, Fenton T, Bachoo RM, et al: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
6	Rich JN, Hans C, Jones B, et al: Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 65:4051–4058. 2005. View Article : Google Scholar : PubMed/NCBI
7	Feng J, Zhang X, Zhu H, Wang X, Ni S and Huang J: High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer. Am J Clin Pathol. 138:230–235. 2012. View Article : Google Scholar : PubMed/NCBI
8	Koon HB, Ippolito GC, Banham AH and Tucker PW: FOXP1: a potential therapeutic target in cancer. Expert Opin Ther Targets. 11:955–965. 2007. View Article : Google Scholar : PubMed/NCBI
9	Green MR, Gandhi MK, Courtney MJ, Marlton P and Griffiths L: Relative abundance of full-length and truncated FOXP1 isoforms is associated with differential NFkappaB activity in Follicular Lymphoma. Leuk Res. 33:1699–1702. 2009. View Article : Google Scholar : PubMed/NCBI
10	Hu H, Wang B, Borde M, et al: Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 7:819–826. 2006. View Article : Google Scholar : PubMed/NCBI
11	Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D and Morrisey EE: Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development. 134:1991–2000. 2007. View Article : Google Scholar : PubMed/NCBI
12	Wlodarska I, Veyt E, De Paepe P, et al: FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia. 19:1299–1305. 2005. View Article : Google Scholar : PubMed/NCBI
13	Lenz G, Wright GW, Emre NC, et al: Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA. 105:13520–13525. 2008. View Article : Google Scholar : PubMed/NCBI
14	Adams H, Tzankov A, Lugli A and Zlobec I: New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma. J Clin Pathol. 62:986–997. 2009. View Article : Google Scholar : PubMed/NCBI
15	Hoeller S, Schneider A, Haralambieva E, Dirnhofer S and Tzankov A: FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1. Histopathology. 57:73–80. 2010. View Article : Google Scholar
16	Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL and Banham AH: Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1alpha expression. Mod Pathol. 19:9–16. 2006. View Article : Google Scholar
17	Bates GJ, Fox SB, Han C, et al: Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas. Breast Cancer Res Treat. 111:453–459. 2008. View Article : Google Scholar : PubMed/NCBI
18	Takayama K, Horie-Inoue K, Ikeda K, et al: FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells. Biochem Biophys Res Commun. 374:388–393. 2008. View Article : Google Scholar
19	Toma MI, Weber T, Meinhardt M, et al: Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma. Cancer Invest. 29:123–129. 2011. View Article : Google Scholar : PubMed/NCBI
20	Fox SB, Brown P, Han C, et al: Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas. Clin Cancer Res. 10:3521–3527. 2004. View Article : Google Scholar : PubMed/NCBI
21	Wei KC, Huang CY, Chen PY, et al: Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res. 30:253–259. 2010.PubMed/NCBI
22	Barbaric D, Dalla-Pozza L and Byrne JA: A reliable method for total RNA extraction from frozen human bone marrow samples taken at diagnosis of acute leukaemia. J Clin Pathol. 55:865–867. 2002. View Article : Google Scholar : PubMed/NCBI
23	Kelleher KL, Leck KJ, Hendry IA and Matthaei KI: A one-step quantitative reverse transcription polymerase chain reaction procedure. Brain Res Brain Res Protoc. 6:100–107. 2001. View Article : Google Scholar : PubMed/NCBI
24	Su F, Li H, Yan C, Jia B, Zhang Y and Chen X: Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells. J Cancer Res Clin Oncol. 135:1655–1663. 2009. View Article : Google Scholar : PubMed/NCBI
25	Li C and Tucker PW: DNA-binding properties and secondary structural model of the hepatocyte nuclear factor 3/fork head domain. Proc Natl Acad Sci USA. 90:11583–11587. 1993. View Article : Google Scholar : PubMed/NCBI
26	Banham AH, Beasley N, Campo E, et al: The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 61:8820–8829. 2001.PubMed/NCBI
27	Shi C, Sakuma M, Mooroka T, et al: Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood. 112:4699–4711. 2008. View Article : Google Scholar : PubMed/NCBI
28	Zhang Y, Li S, Yuan L, et al: Foxp1 coordinates cardiomyocyte proliferation through both cell-autonomous and nonautonomous mechanisms. Gen Dev. 24:1746–1757. 2010. View Article : Google Scholar : PubMed/NCBI
29	Banham AH, Boddy J, Launchbury R, et al: Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate. 67:1091–1098. 2007. View Article : Google Scholar